Key Points Robert More reported the sale of 246,871 shares on Nov. 21 as part of a Rule 10b5-1 trading plan. The director still owns nearly 4 million shares, worth approximately $77.6 million. The stock is up more than 80% year to date, but the company has yet to generate any revenue. These 10 stocks could mint the next wave of millionaires › On Nov. 21, 2025, Robert J. More, Director of Tyra Biosciences (NASDAQ:TYRA), executed an open-market sale of 246,871 shares; see the SEC Form 4 filing for ...